The DOI matches its Crossref record.
Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors
Open accessAbstract
The cannabinoid receptor antagonist SR141716A has been suggested to be an inverse agonist at CB 1 receptors in some isolated intact tissues. We found that the basal incorporation of [35 S]‐GTPγS in Chinese hamster ovary cells expressing human recombinant CB 1 and CB 2 receptors was inhibited by SR141716A (mean pEC 50 s 8.26 and 6.00, respectively), whereas cannabinol (10 μ M) had no significant effect at hCB 1 receptors but inhibited the binding at hCB 2 receptors. As cannabinol had no effect on basal [35 S]‐GTPγS binding at hCB 1 at a concentration 100 fold higher than its binding affinity (Ki=0.1 μ M), we conclude that endogenous cannabinoid receptor agonists are not a confounding factor and suggest the actions of SR141716A at the hCB 1 receptor, and the actions of SR141716A and cannabinol at the hCB 2 receptor, are due to inverse agonism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & de Ceballos, M. L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 785
Cannabidiol: State of the art and new challenges for therapeutic applications
Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., Abate, M., Faggiana, G., Proto, M. C., Fiore, D., et al. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.041 · Cited by 614
Cannabinoid receptors and their ligands
Pertwee, R. G., & Ross, R. A. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0341 · Cited by 561
Insulin resistance and atherosclerosis
Semenkovich, C. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29024 · Cited by 481
Metadata
- Authors
- MacLennan, S. J., Reynen, P. H., Kwan, J., & Bonhaus, D. W.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1998-06
- Volume
- 124
- Issue
- 4
- Pages
- 619-622
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2015708394
- Cited by
- 175
- References
- 0
- FWCI
- 11.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors. https://app.cochat.ai/papers/10.1038/sj.bjp.0701915
- The paper
- MacLennan, S. J., Reynen, P. H., Kwan, J., & Bonhaus, D. W. (1998). Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0701915
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.